Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin P Dinney

Showing results (191-200 of 202) with videos related to

Pageof 21
Sort By:
Urologic Oncology|February 15, 2020
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancerDavid D'Andrea, Peter C Black, Homayoun Zargar, et al.
World Journal of Urology|August 9, 2021
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancerDavid D'Andrea, Peter C Black, Homayoun Zargar, et al.
European Urology|February 11, 2020
Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al.
World Journal of Urology|September 28, 2022
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancerSarah M H Einerhand, Anna J Black, Homayoun Zargar, et al.
Urologic Oncology|November 3, 2019
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomyAnna J Black, Homayoun Zargar, Kamran Zargar-Shoshtari, et al.
European Urology|September 27, 2014
Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancerHomayoun Zargar, Patrick N Espiritu, Adrian S Fairey, et al.
Nature Genetics|August 4, 2009
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancerXifeng Wu, Yuanqing Ye, Lambertus A Kiemeney, et al.
Human Molecular Genetics|August 10, 2011
A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3Montserrat Garcia-Closas, Yuanqing Ye, Nathaniel Rothman, et al.
Human Molecular Genetics|October 29, 2013
Genome-wide association study identifies multiple loci associated with bladder cancer riskJonine D Figueroa, Yuanqing Ye, Afshan Siddiq, et al.
Nature Genetics|October 26, 2010
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility lociNathaniel Rothman, Montserrat Garcia-Closas, Nilanjan Chatterjee, et al.
Pageof 21

Showing results (191-200 of 202) with videos related to

Sort By:
Pageof 21
Urologic Oncology|February 15, 2020
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancerDavid D'Andrea, Peter C Black, Homayoun Zargar, et al.
World Journal of Urology|August 9, 2021
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancerDavid D'Andrea, Peter C Black, Homayoun Zargar, et al.
European Urology|February 11, 2020
Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al.
World Journal of Urology|September 28, 2022
Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancerSarah M H Einerhand, Anna J Black, Homayoun Zargar, et al.
Urologic Oncology|November 3, 2019
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomyAnna J Black, Homayoun Zargar, Kamran Zargar-Shoshtari, et al.
European Urology|September 27, 2014
Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancerHomayoun Zargar, Patrick N Espiritu, Adrian S Fairey, et al.
Nature Genetics|August 4, 2009
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancerXifeng Wu, Yuanqing Ye, Lambertus A Kiemeney, et al.
Human Molecular Genetics|August 10, 2011
A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3Montserrat Garcia-Closas, Yuanqing Ye, Nathaniel Rothman, et al.
Human Molecular Genetics|October 29, 2013
Genome-wide association study identifies multiple loci associated with bladder cancer riskJonine D Figueroa, Yuanqing Ye, Afshan Siddiq, et al.
Nature Genetics|October 26, 2010
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility lociNathaniel Rothman, Montserrat Garcia-Closas, Nilanjan Chatterjee, et al.
Pageof 21